GRAL Competitors & Alternatives
Compare GRAIL, LLC with similar stocks in the same industry
Diagnostics & Research
GRAL
Main Stock$79.54
Tradestie Score
40
Market Cap
$2.24B
Revenue Growth
0.3%
Analyst Upside
-9.0%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SHC
Sotera Health Company Common Stock
|
$19.57
|
$4.60B | 33.1 | 46 | Compare |
|
BLLN
BLLN
|
$95.03
|
$4.50B | 128.7 | 68 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$87.07
|
$3.26B | - | 39 | Compare |
|
VCYT
Veracyte, Inc.
|
$42.31
|
$2.85B | 29.9 | 65 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.99
|
$2.22B | - | 50 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$145.59
|
$1.77B | - | 42 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$49.09
|
$1.50B | - | 38 | Compare |
|
NEOG
Neogen Corp
|
$11.95
|
$1.26B | - | 42 | Compare |
|
OPK
Opko Health Inc.
|
$1.48
|
$1.23B | - | 39 | Compare |
|
NEO
NeoGenomics, Inc.
|
$16.98
|
$1.13B | - | 40 | Compare |
More GRAL Analysis
Data updated: Aug 22, 2026 | Industry: Diagnostics & Research (SIC 8071)
35 stocks in this industry